ALK and anaplastic large cell lymphoma: Confirmation of BIA-ALCL was based on immunohistochemical/flow cytometry findings by a clinical pathologist and included pleiomorphic cells being CD3+, CD4+, CD30+, and anaplastic lymphoma kinase protein negative (ALK−).